Frederick M. Hudson Supernus Pharmaceuticals, Inc. (SUPN) insider trading activity

Frederick M. Hudson is Director of SUPERNUS PHARMACEUTICALS, INC.. Currently has a direct ownership of 61,307 shares of SUPN, which is worth approximately $2.76 Million. The most recent transaction as insider was on Jan 09, 2026, when has been sold 15,000 shares (Common Stock) at a price of $12.98 per share, resulting in proceeds of $194,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 61.3K

32.39% 3M change

115.91% 12M change

Total Value Held $2.76 Million

Frederick M. Hudson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 09 2026	BUY Exercise of conversion of derivative security	$194,700 $12.98 p/Share	15,000 Added 19.66%	61,307 Common Stock
Aug 14 2025	SELL Open market or private sale	$315,132 $42.26 p/Share	7,457 Reduced 13.87%	46,307 Common Stock
Feb 22 2025	BUY Grant, award, or other acquisition	-	5,369 Added 9.08%	53,764 Common Stock
Jan 22 2025	BUY Exercise of conversion of derivative security	$182,600 $9.13 p/Share	20,000 Added 29.24%	48,395 Common Stock
Nov 08 2024	SELL Open market or private sale	$316,434 $36.28 p/Share	8,722 Reduced 23.5%	28,395 Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	3,886 Added 9.48%	37,117 Common Stock
Nov 15 2023	SELL Open market or private sale	$259,150 $28.5 p/Share	9,093 Reduced 21.48%	33,231 Common Stock

Nov 15 2023	BUY Exercise of conversion of derivative security	$68,902 $9.24 p/Share	7,457 Added 14.98%	42,324 Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	3,882 Added 10.02%	34,867 Common Stock
Jan 10 2023	BUY Exercise of conversion of derivative security	$68,903 $7.9 p/Share	8,722 Added 21.97%	30,985 Common Stock
Feb 19 2022	BUY Grant, award, or other acquisition	-	4,222 Added 15.94%	22,263 Common Stock

Also insider at

SCPH

scPharmaceuticals Inc. Healthcare

FMH